AXL and colorectal neoplasm: Clinically, miR-34 targets showed upregulation in primary colorectal tumors (1–2 fold as compared to healthy colorectal tissue) and their expression was correlated with lymph-node metastases (INHBB, AXL, FGFR1, and PDFGRB) and survival (INHBB and AXL) [124].